Addressing hot topics in general practice: Meningococcal B vaccination - QI&CPD - Category 2

Duration

2 hrs

Profession

Physician

# of Credits

4.0

Accreditation

QI&CPD - Category 2

Expiry Date

2020-12-21

Invasive meningococcal disease (IMD) is responsible for serious morbidity and mortality with global estimates of 50,000-135,000 deaths annually. Due to the early non-specific symptoms of IMD, misdiagnosis is common and often results in late medical intervention. Despite the availability of antibiotic therapy, case fatality rate for IMD serogroups B and C among Australian children below 5 years of age is 5%; and 6-12% for adults over the age of 25. Moreover approximately 10-30% of people who survive IMD develop long-term consequences such as limb deformity, limb scarring, deafness and neurological deficits. In this program GPs can update their IMD awareness so that they are more familiar with which variants of IMD are prevalent, how to diagnose it, how to recommend vaccinations and make sure all at risk groups are covered with immunisations.

This activity has been approved by The Royal Australian College of General Practitioners QI&CPD Program. Total Points: 4 Point(s) (Category 2)

N/A

Lisa Beecham
MBBS, FRACGP
Robina Town Centre Medical Centre, QLD

Professor Robert Booy
MBBS (Hons), MSc, MD, FRACP, FRCPCH
Head, Clinical Research
National Centre for Immunisation Research and Surveillance
Westmead Children’s Hospital

N/A



Related Courses